IBD and pregnancy.
Marteau
Philippe
P
Lariboisiere Hospital, Paris, France.
D000328:Adult; D005242:Fecal Incontinence; D005260:Female; D005765:Gastrointestinal Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007248:Infertility, Male / Q000139:chemically induced*; D015212:Inflammatory Bowel Diseases / Q000150:complications* / Q000453:epidemiology / Q000473:pathology / Q000628:therapy; D008297:Male; D011247:Pregnancy; D011248:Pregnancy Complications / Q000453:epidemiology* / Q000209:etiology; D011256:Pregnancy Outcome; D011297:Prenatal Exposure Delayed Effects; D012720:Severity of Illness Index; D012735:Sexual Dysfunction, Physiological; D012460:Sulfasalazine / Q000009:adverse effects* / Q000627:therapeutic use; D016896:Treatment Outcome
D005765:Gastrointestinal Agents; D012460:Sulfasalazine